Antidiabetic agents
US6077849A · kind A · utility
2Cited by
5References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 1999 |
| Grant date | Jun 20, 2000 |
| Priority date | — |
| Expiry date | Mar 29, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula I: ##STR1## as well as tautomers, pharmaceutically acceptable salts, hydrates, prodrugs and reduced forms are disclosed. The compounds are useful for the treatment and prevention of diabetes mellitus, and in particular, for the treatment or prevention of hyperglycemia in diabetic patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.